FerroptoCure CEO Yuji Otsuki Featured on TV Tokyo’s “Breakthrough”

FerroptoCure Inc. (Headquarters: Tokyo, Japan; CEO: Yuji Otsuki) is pleased to announce that its CEO, Yuji Otsuki, was featured on the economic documentary program “Breakthrough” broadcast by TV Tokyo on September 6, 2025.

The program highlighted FerroptoCure’s pioneering efforts in the development of an oral ferroptosis-inducing anticancer drug. Our mission is to provide new treatment options for patients with refractory and rare cancers that have developed resistance to existing therapies. The broadcast introduced the scientific background, research progress, and future prospects of our development program.

As a Keio University School of Medicine spin-off biotech venture, FerroptoCure is accelerating its research and development to deliver new hope to patients through innovative drug discovery targeting ferroptosis, a novel form of regulated cell death. We are honored that this program has provided an opportunity for more people to learn about our initiatives.

Program details can be viewed at the following links:
👉 TV Tokyo Official Website
👉 TVer Streaming